See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 7, 2005

Multiple Sclerosis Diabetic Neuropathy Obesity

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

A research study for patients with relapsing-remitting or secondary progressive multiple sclerosis. Volunteers between ages 18 and 55 who have a diagnosis of active relapsing remitting or secondary progressive multiple sclerosis, and have had at least one relapse within 12 months of screening, may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Diabetic Neuropathy

An experimental research study of an investigational medication taken twice daily for painful diabetic peripheral neuropathy. If you are at least 18 years old and have diabetic neuropathy, you may qualify for this study. Research site located in Englewood, NJ.

More Information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Obesity

A research study to evaluate a new dietary supplement for its effectiveness on weight loss and its ability to satisfy hunger. Healthy volunteers between ages 18 and 65 may be eligible for this 12-week study. Research sites located in Huntington, NY, and Great Neck, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat107.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.